Photodynamic therapy in dermatology.

Area of Science:

• Dermatology
• Photomedicine
• Oncology

Background:

• Topical photodynamic therapy (PDT) is approved for treating skin cancers like basal cell carcinoma and actinic keratoses.
• PDT also shows therapeutic benefits for non-neoplastic skin conditions such as acne vulgaris and localized scleroderma.
• Newer topical photosensitizers like 5-aminolevulinic acid (ALA) and its methyl ester (MAL) induce localized photosensitization, unlike older systemic agents.

Purpose of the Study:

• To review the applications and efficacy of topical photodynamic therapy (PDT) in dermatology.
• To highlight the mechanism of action and advantages of ALA and MAL in PDT.
• To discuss the treatment outcomes, including efficiency and cosmetic results, of PDT for various skin conditions.

Main Methods:

• Review of current literature on topical photodynamic therapy (PDT).
• Discussion of photosensitizers (ALA, MAL) and light activation methods (incoherent lamps, LED arrays).
• Analysis of PDT's mechanism involving reactive oxygen intermediates and their effects on diseased tissue.

Main Results:

• Topical PDT is highly efficient and minimally invasive for superficial non-melanoma skin cancers.
• PDT demonstrates efficacy in treating non-neoplastic dermatological conditions.
• The use of ALA and MAL minimizes generalized cutaneous photosensitization.
• Treatment yields excellent cosmetic results.

Conclusions:

• Topical PDT is a valuable, minimally invasive treatment option for both oncologic and non-neoplastic skin diseases.
• The development of topical photosensitizers has improved the safety and applicability of PDT.
• PDT offers significant therapeutic benefits with favorable cosmetic outcomes.